Insider Trading Alert - Aqua America And 3 Others Traded By Insiders

Yesterday, July 3, 2013, 489 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.00 to $202,421,072.70.

Highlighted Stocks Traded by Insiders:

Aqua America (WTR) - FREE Research Report

Smeltzer David who is Executive VP & CFO at AQUA AMER INC bought 36,320 shares at $15.83 per share for a total value of $379,800.00 on July 1, 2013. Following this transaction, the Executive VP & CFO owned 154,592 shares meaning that the stake was boosted by 27.05% with the 36,320 share acquisition.

The shares most recently traded at $30.94, up $0.21, or 0.68% since the insider transaction. Historical insider transactions for Aqua America go as follows:

  • 4-Week # shares sold: 3,400
  • 12-Week # shares sold: 3,400
  • 24-Week # shares sold: 5,407

The average volume for Aqua America has been 730,300 shares per day over the past 30 days. Aqua America has a market cap of $4.3 billion and is part of the utilities sector and utilities industry. Shares are up 20.89% year to date as of the close of trading on Tuesday.

Aqua America, Inc., through its subsidiaries, operates regulated utilities that provide water or wastewater services in the United States. The stock currently has a dividend yield of 2.48%. The company has a P/E ratio of 21.6. Currently there are 4 analysts that rate Aqua America a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WTR - FREE

TheStreet Quant Ratings rates Aqua America as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Aqua America Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Molson Coors Brewing Company (TAP) - FREE Research Report

Bellini Francesco who is Director at MOLSON COORS-B bought 523 shares on June 30, 2013. Following this transaction, the Director owned 34,400 shares meaning that the stake was boosted by 1.54% with the 523 share acquisition.

Eaton Roger G. who is Director at MOLSON COORS-B bought 523 shares on June 30, 2013. Following this transaction, the Director owned 6,940 shares meaning that the stake was boosted by 8.15% with the 523 share acquisition.

Goldner Brian who is Director at MOLSON COORS-B bought 523 shares on June 30, 2013. Following this transaction, the Director owned 13,668 shares meaning that the stake was boosted by 3.98% with the 523 share acquisition.

Herington Charles M who is Director at MOLSON COORS-B bought 523 shares on June 30, 2013. Following this transaction, the Director owned 30,605 shares meaning that the stake was boosted by 1.74% with the 523 share acquisition.

Hobbs Franklin W Iv who is Director at MOLSON COORS-B bought 575 shares on June 30, 2013. Following this transaction, the Director owned 41,162 shares meaning that the stake was boosted by 1.42% with the 575 share acquisition.

Napier Iain J G who is Director at MOLSON COORS-B bought 601 shares on June 30, 2013. Following this transaction, the Director owned 13,338 shares meaning that the stake was boosted by 4.72% with the 601 share acquisition.

Riley H Sanford who is Director at MOLSON COORS-B bought 575 shares on June 30, 2013. Following this transaction, the Director owned 35,785 shares meaning that the stake was boosted by 1.63% with the 575 share acquisition.

Vachon Louis who is Director at MOLSON COORS-B bought 523 shares on June 30, 2013. Following this transaction, the Director owned 6,940 shares meaning that the stake was boosted by 8.15% with the 523 share acquisition.

The shares most recently traded at $47.54, down $0.53, or 1.1% since the insider transactions. Historical insider transactions for Molson Coors Brewing Company go as follows:

  • 4-Week # shares sold: 7,642
  • 12-Week # shares sold: 39,596
  • 24-Week # shares sold: 40,930

The average volume for Molson Coors Brewing Company has been 1.3 million shares per day over the past 30 days. Molson Coors Brewing Company has a market cap of $7.6 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 12.32% year to date as of the close of trading on Tuesday.

Molson Coors Brewing Company manufactures and sells beer and other beverage products. The stock currently has a dividend yield of 2.66%. The company has a P/E ratio of 22.0. Currently there is 1 analyst that rates Molson Coors Brewing Company a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TAP - FREE

TheStreet Quant Ratings rates Molson Coors Brewing Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Molson Coors Brewing Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Covidien (COV) - FREE Research Report

Almeida Jose E who is President and Chief Executive at COVIDIEN sold 979 shares at $57.41 per share for a total value of $56,204.39 on July 1, 2013. Following this transaction, the President and Chief Executive owned 212,478 shares meaning that the stake was reduced by 0.46% with the 979 share sell-off.

Hanson Bryan C who is Senior Vice President at COVIDIEN sold 224 shares at $57.41 per share for a total value of $12,859.84 on July 1, 2013. Following this transaction, the Senior Vice President owned 21,741 shares meaning that the stake was reduced by 1.02% with the 224 share sell-off.

Sgrignari Michael who is Senior Vice President at COVIDIEN sold 53 shares at $57.41 per share for a total value of $3,042.73 on July 1, 2013. Following this transaction, the Senior Vice President owned 22,096 shares meaning that the stake was reduced by 0.24% with the 53 share sell-off.

Wehrly Peter L who is Senior Vice President at COVIDIEN sold 273 shares at $57.41 per share for a total value of $15,672.93 on July 1, 2013. Following this transaction, the Senior Vice President owned 24,985 shares meaning that the stake was reduced by 1.08% with the 273 share sell-off.

The shares most recently traded at $57.76, up $0.64, or 1.12% since the insider transactions. Historical insider transactions for Covidien go as follows:

  • 4-Week # shares sold: 2,652
  • 12-Week # shares sold: 19,180
  • 24-Week # shares sold: 29,180

The average volume for Covidien has been 3.3 million shares per day over the past 30 days. Covidien has a market cap of $27.0 billion and is part of the health care sector and health services industry. Shares are down 0.57% year to date as of the close of trading on Tuesday.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 14.9. Currently there are 14 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COV - FREE

TheStreet Quant Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Covidien Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Hospira (HSP) - FREE Research Report

Ramachandra Sumant who is Senior Vice President and CSO at HOSPIRA INC bought 18,115 shares on June 28, 2013. Following this transaction, the Senior Vice President and CSO owned 38,739 shares meaning that the stake was boosted by 87.83% with the 18,115 share acquisition.

Sokolov Jacque J who is Director at HOSPIRA INC bought 5,564 shares on June 28, 2013. Following this transaction, the Director owned 42,771 shares meaning that the stake was boosted by 14.95% with the 5,564 share acquisition.

The shares most recently traded at $38.45, down $0.16, or 0.41% since the insider transactions.

The average volume for Hospira has been 1.2 million shares per day over the past 30 days. Hospira has a market cap of $6.5 billion and is part of the health care sector and drugs industry. Shares are up 23.59% year to date as of the close of trading on Tuesday.

Hospira, Inc. provides injectable drugs and infusion technologies to develop, manufacture, distribute, and markets products worldwide. Currently there are no analysts that rate Hospira a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HSP - FREE

TheStreet Quant Ratings rates Hospira as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and weak operating cash flow. Get the full Hospira Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Italian Bonds Slump as Government Mulls Anti-Euro Finance Minister

Italian Bonds Slump as Government Mulls Anti-Euro Finance Minister

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

One Thing to Consider Over Memorial Day Weekend: Are Stocks About to Collapse?

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)